Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation. Nukaly HY, Srikakolapu S, Elston DM. Cutis 2026;117:191-192.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nukaly HY, Srikakolapu S, Elston DM. Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation. Cutis 2026;117:191-192.
PMID: 42594396